FDA Approval History
This list consists of medications tracked by Drugs.com through the application and approval process at the U.S. Food and Drug Administration (FDA) since 2004. Where possible, we have assembled information in chronological order to show the history of a medication. May only show partial information and does not include non-US drug approvals. For information about non-US medications, please visit the international drugs section.
Latest Drug Approvals
- Trelegy Ellipta (fluticasone furoate, umeclidinium and vilanterol) - September 18, 2017
- Xhance (fluticasone propionate) - September 18, 2017
- Adzenys ER (amphetamine) - September 15, 2017
- Solosec (secnidazole) - September 15, 2017
- Aliqopa (copanlisib) - September 14, 2017
- Mvasi (bevacizumab-awwb) - September 14, 2017
- Mylotarg (gemtuzumab ozogamicin) - September 01, 2017
- Kymriah (tisagenlecleucel) - August 30, 2017
- (benznidazole) - August 29, 2017
- Vabomere (meropenem and vaborbactam) - August 29, 2017
- Cyltezo (adalimumab-adbm) - August 25, 2017
- Gocovri (amantadine hydrochloride) - August 24, 2017
- KedRAB (rabies immunoglobulin human) - August 23, 2017
- Duzallo (allopurinol and lesinurad) - August 18, 2017
- Besponsa (inotuzumab ozogamicin) - August 17, 2017
- CaroSpir (spironolactone) - August 04, 2017
- Mavyret (glecaprevir and pibrentasvir) - August 03, 2017
- Vyxeos (cytarabine and daunorubicin) - August 03, 2017
- Idhifa (enasidenib) - August 01, 2017
- Vosevi (sofosbuvir, velpatasvir and voxilaprevir) - July 18, 2017
